Tue, August 20, 2024
Mon, August 19, 2024
Fri, August 16, 2024
Thu, August 15, 2024

Andrew Berens Downgraded (VIRX) to Hold and Decreased Target to $3 on, Aug 16th, 2024


//stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-3-on-aug-16th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Andrew Berens of Leerink Partners, Downgraded "Viracta Therapeutics, Inc." (VIRX) to Hold and Decreased Target from $5 to $3 on, Aug 16th, 2024.

Andrew has made no other calls on VIRX in the last 4 months.



There are 3 other peers that have a rating on VIRX. Out of the 3 peers that are also analyzing VIRX, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $4 on, Thursday, August 15th, 2024
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $11 on, Thursday, May 23rd, 2024
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $4 on, Tuesday, April 16th, 2024

Publication Contributing Sources